US Patent 8153102 Process for manufacturing pharmaceutical composition comprises of
Patent 8153102 was granted and assigned to Cadila Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+193 characters)
Article
Patent abstract
The invention relates to process for the preparation of formulations comprising a microorganism Mycobacterium w for the management of bronchial Asthma (obstructive lung disease).
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08153102 Process for manufacturing pharmaceutical composition comprises of US Patent 8153102 Process for manufacturing pharmaceutical composition comprises of
Infobox
Patent Number
0815310200
Patent Number
815310200
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081531020
Date of Patent
April 10, 2012
0Patent Application Number
105652110
Date Filed
March 11, 2003
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081531020
Date of Patent
April 10, 2012
0Patent Application Number
105652110
Date Filed
March 11, 2003
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08153102 Process for manufacturing pharmaceutical composition comprises of
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08153102
Date of patent
April 10, 2012
Patent application number
10565211
Date Filed
March 11, 2003
Patent primary examiner
Find more entities like US Patent 8153102 Process for manufacturing pharmaceutical composition comprises of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.